Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Discovery and Characterization of Super-Enhancer Associated Dependencies in Diffuse Large B-Cell Lymphoma
PubMed Full text in PMC Similar studies SRA Run Selector
Time course gene expression profiling of five diffuse large B-cell lymphoma cell lines following JQ1 treatment
PubMed Full text in PMC Similar studies Analyze with GEO2R
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers [Affymetrix]
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers [ChIP-seq]
The BET Bromodomain Inhibitor OTX015/MK-8628 modulates microRNA expression in Diffuse Large B-Cell Lymphoma
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma
PubMed Full text in PMC Similar studies
Chromatin looping evidence between PAX3-FOXO1 bound super enhancer and MYOD1 promoter [4C-seq]
PAX3-FOXO1 establishes myogenic super enhancers [RMS Chip-seq]
PAX3-FOXO1 establishes myogenic super enhancers and recruits BRD4 de novo [7250 ChIP-seq]
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq]
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
RNAPol2 accounts for tumor cells liability to JQ1
RNAPol2 accounts for tumor cells liability to JQ1 [ChIP-Seq]
RNAPol2 accounts for tumor cells liability to JQ1 [Affymetrix]
BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia
BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia [ChIP-Seq]
BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia [RNA-Seq]
Treatment of primary effusion lymphoma cell lines with lenalidomide
Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibition
Super-enhancer-mediated RNA processing revealed by integrative microRNA network analysis
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on